mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.5 |